Physician
Kapadia, Mehbub
Kapadia, Mehbub was paid $515K by Medicaid between Jan 2021 and Nov 2024, across 26 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 14% of everything it billed.
33Billing provider infoKAPADIA, MEHBUB
CHICAGO, IL 60654
CHICAGO, IL 60654
33aNPI1558584391assigned 04/10/2007
33bProvider typeClinical & Laboratory Immunology (Internal Medicine) Physician
28Total paid$515K
24GClaims16,128
24DCodes billed26
24AFirst – last monthJan 2021 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 6,522 | $220K | |
| 2022 | 4,634 | $136K | |
| 2023 | 2,061 | $79K | |
| 2024incomplete | 2,911 | $79K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 14% | 2,070 | 1,734 | $72K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13% | 896 | 731 | $69K |
| 91320 | 13% | 511 | 363 | $69K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8.1% | 5,162 | 2,635 | $42K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.4% | 1,642 | 1,454 | $38K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.7% | 865 | 273 | $34K |
| 0011A | 5.5% | 718 | 634 | $28K | |
| 0012A | 5.4% | 678 | 629 | $28K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 5.1% | 849 | 816 | $26K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.9% | 533 | 500 | $25K |
| 0002A | 4.2% | 531 | 491 | $21K | |
| 0001A | 3.2% | 574 | 554 | $16K |
14 more codes
| 90678 | 2.6% | 53 | $13K | |
| 90480 | 2.5% | 321 | $13K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.2% | 47 | $6K |
| 90656 | <1% | 155 | $3K | |
| 0004A | <1% | 58 | $2K | |
| 0064A | <1% | 46 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 84 | $2K |
| 90756 | <1% | 50 | $2K | |
| 90673 | <1% | 26 | $1K | |
| 90662 | <1% | 14 | $284.22 | |
| G0008 | Administration of influenza virus vaccine | <1% | 13 | $79.02 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 81 | $33.16 |
| 91301 | <1% | 58 | $0.07 | |
| 91300 | <1% | 93 | $0.03 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.